Dainippon Sumitomo Temporarily Halts Marketing Operations In Kansai Region Due To Flu
This article was originally published in PharmAsia News
Executive Summary
Due to increasing new HIN1 flu cases in Japan's Kansai region, Dainippon Sumitomo Pharmaceutical May 18 temporarily halted medical representatives' marketing activities in six Prefectures including Osaka and Hyogo until May 22. (Click here for more - Japanese language